There is an established process—it even has an acronym—and decision-makers are boasting about its importance, enduring effectiveness, and operation that is entirely consistent with the existing legal framework for HTA decision-making. Stakeholders should demand its more comprehensive application. …
Why not use the rHTA process that's 'consistent' with existing framework?
April 8, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
OncoSil completes first production run at new Sydney manufacturing facility
December 17, 2025 - - Australian Biotech -
Island Pharmaceuticals secures key partnership with Texas Biomed
December 17, 2025 - - Australian Biotech -
Novartis names new Country President following leadership transition
December 16, 2025 - - Latest News -
Mayne Pharma opens expanded manufacturing facility after termination of takeover
December 16, 2025 - - Latest News -
Budget update includes impact of listings, but generally not much else
December 16, 2025 - - Latest News -
The UK reconfirms the direct impact of the transatlantic shift in medicine pricing
December 16, 2025 - - Latest News -
The industry is probably right to resist, it just needs to prepare for the response
December 16, 2025 - - Latest News